Doseology Sciences Inc. (CSE: MOOD)
Canada
· Delayed Price · Currency is CAD
0.250
0.00 (0.00%)
Nov 25, 2024, 4:00 PM EST
Doseology Sciences Statistics
Total Valuation
Doseology Sciences has a market cap or net worth of CAD 1.10 million.
Market Cap | 1.10M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Doseology Sciences has 4.40 million shares outstanding. The number of shares has increased by 18.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.40M |
Shares Change (YoY) | +18.00% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 3.82% |
Owned by Institutions (%) | n/a |
Float | 4.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.67% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +66.67% |
50-Day Moving Average | 0.22 |
200-Day Moving Average | 0.27 |
Relative Strength Index (RSI) | 51.64 |
Average Volume (20 Days) | 1,813 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Doseology Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.00% |
Shareholder Yield | -18.00% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on February 16, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Feb 16, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |